← Leaderboards
Steven J Mennerick
Washington University
$16,806,295
Attributed
$18,519,212
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,686,148 · 16
By mechanism
P50$15,796,000 · 3
R01$10,837,544 · 6
R21$2,483,176 · 6
T32$1,569,428 · 1
Top collaborators
- Charles F Zorumski10 shared
- Theodore J Cicero6 shared
Most similar at Washington University
Same institution · by research overlap
- Charles F Zorumski$12,122,533
- Vesna Jevtovic-Todorovic Jevtovic-Todorovic$12,218,628
- Emad N Eskandar$21,648,225
- Jose A Moron-Concepcion$16,173,892
- John Rogers$13,709,978
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsSynapsesCellsInnovationNeurosteroidsReceptorNeuropsychiatrySignal TransductionMediatingBrainBehaviorSitePharmaceutical PreparationsCell TypeGamma-Aminobutyric AcidHippocampus (Brain)BehavioralLearningPhysiologicalInsightGlutamatesHippocampusPropertyBase
Grant awards (67)
Neuroactive steroids as novel psychiatric treatments: mechanistic studies$2,378,256
P50 · FY2025 · MH · contact PI
Mechanistic studies of Neurosteroid Analogues$524,232
P50 · FY2025 · MH · contact PI
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS$485,067
R01 · FY2025 · MH · contact PI
Administration Core$178,560
P50 · FY2025 · MH · contact PI
Neuroactive steroids as novel psychiatric treatments: mechanistic studies$2,381,313
P50 · FY2024 · MH · contact PI
Mechanistic studies of Neurosteroid Analogues$524,232
P50 · FY2024 · MH · contact PI
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS$485,067
R01 · FY2024 · MH · contact PI
Administration Core$178,560
P50 · FY2024 · MH · contact PI
Neuroactive steroids as novel psychiatric treatments: mechanistic studies$2,426,963
P50 · FY2023 · MH · contact PI
Mechanistic studies of Neurosteroid Analogues$609,336
P50 · FY2023 · MH · contact PI
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS$436,560
R01 · FY2023 · MH · contact PI
Administration Core$178,560
P50 · FY2023 · MH · contact PI
Neuroactive steroids as novel psychiatric treatments: mechanistic studies$2,444,687
P50 · FY2022 · MH · contact PI
Mechanistic studies of Neurosteroid Analogues$539,232
P50 · FY2022 · MH · contact PI
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS$460,815
R01 · FY2022 · MH · contact PI
Administration Core$178,560
P50 · FY2022 · MH · contact PI
Neuroactive steroids as novel psychiatric treatments: mechanistic studies$2,535,717
P50 · FY2021 · MH · contact PI
Mechanistic studies of Neurosteroid Analogues$539,232
P50 · FY2021 · MH · contact PI
GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS$500,069
R01 · FY2021 · MH · contact PI
Administration Core$178,560
P50 · FY2021 · MH · contact PI
Chemogenetic analysis of ethanol's selectivity for GABAA receptor populations$186,784
R21 · FY2020 · AA · contact PI
Chemogenetic analysis of ethanol's selectivity for GABAA receptor populations$222,992
R21 · FY2019 · AA · contact PI
Oxysterols and NMDAR Function$353,600
R01 · FY2018 · MH · contact PI
DOPAMINE INTERACTIONS WITH HIPPOCAMPAL MOSSY CELLS$190,625
R21 · FY2018 · MH · contact PI
Oxysterols and NMDAR Function$361,406
R01 · FY2017 · MH · contact PI
DOPAMINE INTERACTIONS WITH HIPPOCAMPAL MOSSY CELLS$228,750
R21 · FY2017 · MH · contact PI
A CHEMOGENETIC EVALUATION OF DELTA SUBUNIT EXCLUSION FROM GABA SYNAPSES$190,625
R21 · FY2017 · MH · contact PI
Biomedical Research Training in Drug Abuse$1
T32 · FY2017 · DA
Biomedical Research Training in Drug Abuse$389,700
T32 · FY2016 · DA
Oxysterols and NMDAR Function$369,213
R01 · FY2016 · MH · contact PI
A CHEMOGENETIC EVALUATION OF DELTA SUBUNIT EXCLUSION FROM GABA SYNAPSES$228,750
R21 · FY2016 · MH · contact PI
Oxysterols and NMDAR Function$374,416
R01 · FY2015 · MH · contact PI
CONTROL OF SYNAPTIC GLUTAMATE RELEASE$342,000
R01 · FY2015 · MH · contact PI
Biomedical Research Training in Drug Abuse$326,712
T32 · FY2015 · DA
NEUROSTEROIDS AND ANXIETY RELATED NETWORK FUNCTION$190,625
R21 · FY2015 · MH · contact PI
Oxysterols and NMDAR Function$397,771
R01 · FY2014 · MH · contact PI
CONTROL OF SYNAPTIC GLUTAMATE RELEASE$342,000
R01 · FY2014 · MH · contact PI
NEUROSTEROIDS AND ANXIETY RELATED NETWORK FUNCTION$215,625
R21 · FY2014 · MH · contact PI
RECEPTOR POPULATIONS UNDERLYING TONIC GABA CURRENTS IN HIPPOCAMPUS$190,000
R21 · FY2014 · MH · contact PI
Biomedical Research Training in Drug Abuse$122,253
T32 · FY2014 · DA
Biomedical Research Training in Drug Abuse$361,655
T32 · FY2013 · DA
CONTROL OF SYNAPTIC GLUTAMATE RELEASE$328,320
R01 · FY2013 · MH · contact PI
RECEPTOR POPULATIONS UNDERLYING TONIC GABA CURRENTS IN HIPPOCAMPUS$228,000
R21 · FY2013 · MH · contact PI
NICOTINIC MODULATION OF DOPAMINE RELEASE STUDIED WITH A CHANNEL-BASED BIOSENSOR$182,400
R21 · FY2013 · DA · contact PI
Biomedical Research Training in Drug Abuse$369,107
T32 · FY2012 · DA
CONTROL OF SYNAPTIC GLUTAMATE RELEASE$342,000
R01 · FY2012 · MH · contact PI
NICOTINIC MODULATION OF DOPAMINE RELEASE STUDIED WITH A CHANNEL-BASED BIOSENSOR$228,000
R21 · FY2012 · DA · contact PI
CONTROL OF SYNAPTIC GLUTAMATE RELEASE$360,604
R01 · FY2011 · MH · contact PI
Axonal Signaling in the Hippocampus$295,886
R01 · FY2010 · NS · contact PI
Control of Synaptic Glutamate Release$282,639
R01 · FY2010 · MH · contact PI
Axonal Signaling in the Hippocampus$298,874
R01 · FY2009 · NS · contact PI
Control of Synaptic Glutamate Release$282,639
R01 · FY2009 · MH · contact PI
Axonal Signaling in the Hippocampus$298,874
R01 · FY2008 · NS · contact PI
Control of Synaptic Glutamate Release$282,639
R01 · FY2008 · MH · contact PI
Axonal Signaling in the Hippocampus$299,120
R01 · FY2007 · NS · contact PI
Control of Synaptic Glutamate Release$282,717
R01 · FY2007 · MH · contact PI
Control of Synaptic Glutamate Release$314,694
R01 · FY2006 · MH · contact PI
Axonal Signaling in the Hippocampus$298,808
R01 · FY2006 · NS · contact PI
In Vitro Mechanisms of Ethanol Induced Neuronal Death.$211,750
R01 · FY2005 · AA
Control of Synaptic Glutamate Release$231,000
R01 · FY2004 · NS
In Vitro Mechanisms of Ethanol Induced Neuronal Death.$211,750
R01 · FY2004 · AA
Control of Synaptic Glutamate Release$231,000
R01 · FY2003 · NS
In Vitro Mechanisms of Ethanol Induced Neuronal Death.$211,750
R01 · FY2003 · AA
Control of Synaptic Glutamate Release$231,000
R01 · FY2002 · NS
In Vitro Mechanisms of Ethanol Induced Neuronal Death.$211,750
R01 · FY2002 · AA
Control of Synaptic Glutamate Release$222,956
R01 · FY2001 · NS
In Vitro Mechanisms of Ethanol Induced Neuronal Death$198,790
R01 · FY2001 · AA